| Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study (NCT02381366) | Medipost, Inc. | 2015-03-01 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer (NCT02048943) | Roswell Park Cancer Institute | 2015-03-01 |
| A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors (NCT02414516) | Oncolys BioPharma Inc | 2015-03-01 |
| A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age (NCT02398669) | Eisai Inc. | 2015-03-01 |
| Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department (NCT02399969) | Icahn School of Medicine at Mount Sinai | 2015-03-01 |
| A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults (NCT02390609) | Janssen Research & Development, LLC | 2015-03-01 |
| Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy (NCT02376816) | Jerry R. Mendell | 2015-03-01 |
| Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome (NCT02656225) | The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | 2015-03-01 |
| Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers (NCT02397590) | Boryung Pharmaceutical Co., Ltd | 2015-03-01 |
| Xanthohumol and Prevention of DNA Damage (NCT02432651) | Oregon State University | 2015-03-01 |
| Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer (NCT02396108) | National University Hospital, Singapore | 2015-03-01 |
| Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population (NCT02493075) | Sir Run Run Shaw Hospital | 2015-03-01 |
| A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients (NCT03006159) | Jiangsu HengRui Medicine Co., Ltd. | 2015-03-01 |
| The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers (NCT02396069) | Jeil Pharmaceutical Co., Ltd. | 2015-03-01 |
| Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru (NCT02124122) | Tulane University School of Medicine | 2015-03-01 |
| Ketamine for Thrombolysis in Acute Ischemic Stroke (NCT02258204) | University Hospital, Caen | 2015-03-01 |
| A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease (NCT02385019) | Instituto de Medicina Molecular João Lobo Antunes | 2015-03-01 |
| C-VISA BikDD: Liposome in Advanced Pancreatic Cancer (NCT00968604) | M.D. Anderson Cancer Center | 2015-03-01 |
| A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound (NCT02394873) | Anterogen Co., Ltd. | 2015-03-01 |
| Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 (NCT02387125) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-02-28 |
| Safety Study of SEA-CD40 in Cancer Patients (NCT02376699) | Seagen Inc. | 2015-02-28 |
| Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel (NCT02366949) | Bayer | 2015-02-27 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| Removal of Beta Blocker Drugs by Hemodialysis (NCT03361280) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-02-27 |
| A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia. (NCT02310321) | Astellas Pharma Inc | 2015-02-26 |
| A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease (NCT02353598) | Genentech, Inc. | 2015-02-26 |
| Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma (NCT01209871) | M.D. Anderson Cancer Center | 2015-02-26 |
| Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids (NCT02379442) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-02-23 |
| Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer (NCT02358200) | Pamela Munster | 2015-02-23 |
| Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects (NCT02322671) | GlaxoSmithKline | 2015-02-23 |
| A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH (NCT02264639) | Apellis Pharmaceuticals, Inc. | 2015-02-23 |
| Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809 (NCT02362516) | Boehringer Ingelheim | 2015-02-23 |
| Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects (NCT02363855) | Bayer | 2015-02-23 |
| Epigenetic Reprogramming in Relapse AML (NCT02412475) | Michael Burke | 2015-02-21 |
| Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors (NCT02324621) | Rutgers, The State University of New Jersey | 2015-02-20 |
| ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (NCT02362035) | Acerta Pharma BV | 2015-02-20 |
| Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma (NCT02220608) | Washington University School of Medicine | 2015-02-20 |
| Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia (NCT02345382) | Bayer | 2015-02-19 |
| Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam (NCT02082665) | GlaxoSmithKline | 2015-02-19 |
| Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery (NCT02291432) | Cook MyoSite | 2015-02-19 |
| Window Trial 5-aza in HNSCC, T-tare (NCT02178072) | Yale University | 2015-02-19 |
| Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer (NCT02292173) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-18 |
| Tau Imaging in Professional Fighters (NCT02278354) | Avid Radiopharmaceuticals | 2015-02-18 |
| Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors (NCT02222363) | Vivolux AB | 2015-02-18 |
| Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients (NCT02253277) | Novartis Pharmaceuticals | 2015-02-18 |
| Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia (NCT02360657) | Janssen Pharmaceutical K.K. | 2015-02-16 |
| Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx (NCT02269020) | Centre Hospitalier Universitaire de Nīmes | 2015-02-16 |
| Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT02303821) | Amgen | 2015-02-16 |
| A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions (NCT01701193) | Temple Therapeutics BV | 2015-02-15 |
| Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (NCT02354131) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2015-02-15 |
| XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers (NCT03441815) | PHARMENTERPRISES LLC | 2015-02-14 |
| The Role of Phosphodiesterase Inhibitors in Incretin Secretion (NCT02363335) | National Institute on Aging (NIA) | 2015-02-13 |
| Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02337426) | Virginia Commonwealth University | 2015-02-13 |
| Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions (NCT02359045) | AstraZeneca | 2015-02-12 |
| Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia (NCT02257138) | M.D. Anderson Cancer Center | 2015-02-12 |
| Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma (NCT01609816) | Barbara Ann Karmanos Cancer Institute | 2015-02-12 |
| Antioxidant Therapy in RYR1-Related Congenital Myopathy (NCT02362425) | National Institute of Nursing Research (NINR) | 2015-02-12 |
| Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers (NCT02371603) | GlaxoSmithKline | 2015-02-11 |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer (NCT02300610) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-11 |
| Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis (NCT02317887) | VegaVect, Inc. | 2015-02-11 |
| Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source (NCT02167958) | Rafic Farah, MD | 2015-02-11 |
| A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC (NCT02346370) | Halozyme Therapeutics | 2015-02-10 |
| Selenium and Arsenic Pharmacodynamics (NCT02377635) | University of Saskatchewan | 2015-02-10 |
| A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients (NCT02323139) | Groupe Francophone des Myelodysplasies | 2015-02-10 |
| Evaluation Of Different Rapid Orthodontic Expansion Devices (NCT03258411) | King Abdulaziz University | 2015-02-10 |
| Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT02009436) | Albert Einstein College of Medicine | 2015-02-09 |
| Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET (NCT03542773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-06 |
| Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (NCT02215512) | EpicentRx, Inc. | 2015-02-06 |
| Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007) (NCT02387372) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-02-05 |
| CCFZ533X2201 - PoC Study in de Novo Renal Transplantation (NCT02217410) | Novartis Pharmaceuticals | 2015-02-05 |
| A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects (NCT02341482) | Biogen | 2015-02-05 |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer (NCT02318771) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-02-05 |
| A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults (NCT02337855) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-04 |
| Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas (NCT02181218) | Washington University School of Medicine | 2015-02-04 |
| A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer (NCT02333370) | Novartis Pharmaceuticals | 2015-02-04 |
| PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers (NCT02359344) | Biogen | 2015-02-03 |
| A Safety and Immune Response Study of 2 Experimental HIV Vaccines (NCT02404311) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-02 |
| Human Umbilical Cord Stroma MSC in Myocardial Infarction (NCT02323477) | Ankara University | 2015-02-02 |
| A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease (NCT02140554) | Genetix Biotherapeutics Inc. | 2015-02-02 |
| Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies (NCT02383212) | Regeneron Pharmaceuticals | 2015-02-02 |
| Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma (NCT02275416) | Ultimovacs ASA | 2015-02-02 |
| Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAH (NCT02403908) | Clinical Hospital Centre Zagreb | 2015-02-01 |
| Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability (NCT03063489) | Bausch Health Americas, Inc. | 2015-02-01 |
| Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS (NCT02369003) | Craig van Horne, MD, PhD | 2015-02-01 |
| A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD) (NCT02363946) | Arrowhead Pharmaceuticals | 2015-02-01 |
| Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers (NCT04039724) | Hanmi Pharmaceutical Company Limited | 2015-02-01 |
| Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects (NCT02370589) | Novavax | 2015-02-01 |
| Role of the Microbiome in Graves' Orbitopathy (NCT02373995) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2015-02-01 |
| A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02376049) | LEO Pharma | 2015-02-01 |
| Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis. (NCT02332148) | CDA Research Group, Inc. | 2015-02-01 |
| Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation (NCT02275936) | Nivalis Therapeutics, Inc. | 2015-02-01 |
| Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD (NCT02318082) | Dana-Farber Cancer Institute | 2015-02-01 |
| A Study of LY3154207 in Healthy Participants (NCT02365571) | Eli Lilly and Company | 2015-02-01 |
| Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine (NCT02289248) | Yale University | 2015-02-01 |
| First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers (NCT02334449) | Novartis Pharmaceuticals | 2015-02-01 |
| Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects (NCT02373930) | ViiV Healthcare | 2015-02-01 |
| Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery (NCT02374229) | Meshalkin Research Institute of Pathology of Circulation | 2015-02-01 |
| Dabigatran in an Interaction Probe Drug Cocktail (NCT02361619) | Turku University Hospital | 2015-02-01 |
| A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC) (NCT02759250) | argenx | 2015-02-01 |
| MEsenchymal StEm Cells for Multiple Sclerosis (NCT02403947) | University Hospital, Toulouse | 2015-02-01 |